Figure 2
From: Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
The relationship between IGFL2 and clinical prognosis. (A) Prognosis of IGFL2 in overall survival. (B) Prognosis of IGFL2 in disease-free survival. (C) Positive correlation between IGFL2 and cancer staging in the GEPIA database.
